Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;2(6):604-6.
doi: 10.1177/1947601911423096.

Cancer Epigenetics for the 21st Century: What's Next?

Affiliations

Cancer Epigenetics for the 21st Century: What's Next?

Manel Esteller. Genes Cancer. 2011 Jun.

Abstract

The discovery of global DNA hypomethylation events in human tumors in the early 1980s and the identification of CpG island promoter hypermethylation of tumor suppressor genes in cancer cells in the mid 1990s opened the door to the current excitement about the contribution of epigenetic disruption to human disease. The recent gigantic advances in technology make it possible to obtain complete DNA methylomes, histonomes, and non-coding RNA transcriptomes for many biological settings and their associated disorders. Furthermore, whole genome sequencing analyses yields an increasing number of mutated epigenetic genes in neoplasia. It is time to sit back, enjoy the show with a little help of friendly bioinformatic tools, and wonder about what will happen next.

Keywords: DNA methylation; cancer; epigenetics; histone; microRNA.

PubMed Disclaimer

References

    1. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 2005;102:10604-9 - PMC - PubMed
    1. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-92 - PMC - PubMed
    1. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433-40 - PubMed
    1. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011;17:330-9 - PubMed
    1. Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000;343:1350-4 - PubMed

LinkOut - more resources